SCHEMBL9003053

SCHEMBL9003053

FC(F)(F)c1ccccc1C(Cl)C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACP3 P15309 1/20 0.43
P2RX7 Q99572 1/20 0.43
CNR2 P34972 2/20 0.42
HSD11B1 P28845 4/20 0.37
IDO1 P14902 3/20 0.37
TDO2 P48775 1/20 0.37
ALDH1A1 P00352 2/20 0.36
POLB P06746 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ATM Q13315 1/20 0.36
MC4R P32245 1/20 0.35
OPRM1 P35372 1/20 0.35
OPRD1 P41143 1/20 0.35
OPRK1 P41145 1/20 0.35
OPRL1 P41146 1/20 0.35
NOTUM Q6P988 1/20 0.34
LMNA P02545 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27738562 0.84 TSHR (0.33) P2RX7ALDH1A1TDP1L3MBTL1KDM4E
SCHEMBL29523337 0.82 ACP3 (0.46) ACP3P2RX7CNR2HSD11B1IDO1
SCHEMBL6564259 0.82 ACP3 (0.46) ACP3P2RX7CNR2HSD11B1IDO1
SCHEMBL10540798 0.80 ACP3 (0.44) ACP3P2RX7CNR2HSD11B1IDO1
SCHEMBL9864039 0.78 ACP3 (0.47) ACP3P2RX7CNR2HSD11B1IDO1
SCHEMBL15129454 0.77 ACP3 (0.42) ACP3P2RX7CNR2HSD11B1IDO1
SCHEMBL29052941 0.77 ACP3 (0.54) ACP3P2RX7CNR2HSD11B1IDO1
SCHEMBL10546400 0.75 ACP3 (0.47) ACP3P2RX7CNR2HSD11B1IDO1
SCHEMBL3987454 0.74 GABRA1 (0.46) ALDH1A1POLBTDP1L3MBTL1KDM4E
SCHEMBL308175 0.74 ACP3 (0.47) ACP3P2RX7CNR2HSD11B1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0731790-A1 TACHYKININ ANTAGONISTS A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L. (IT) 1996-09-18 EP disclosed